DGX
HealthcareQuest Diagnostics Incorporated
$199.39-1.49 (-0.74%)
Prev Close
$200.88
Open
$202.84
High
$205.00
Low
$199.39
Volume
435.8K
Market Cap
$23.26B
P/E
22.79
Div Yield
—
Over the past 12 months, insider activity at Quest Diagnostics Incorporated (DGX) has been exclusively selling, with 0 insider purchases totaling $0.00 and 57 insider sales totaling $56.87M. The most recent insider transaction was by Doherty Catherine T. (officer: EVP, Regional Businesses), who sold $1.15M worth of shares on Mar 6, 2026. Quest Diagnostics Incorporated operates in the Healthcare sector, within the Medical - Diagnostics & Research industry, with a market cap of $23.26B.
Buys (12M)
0
$0.00
Sells (12M)
57
$56.87M
Net Activity
Net Seller
$56.87M
Active Insiders
12
last 12 mo
DGX Price Chart
DGX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 6, 2026↗ | Doherty Catherine T. | officer: EVP, Regional Businesses | Sell | 5,558 | $206.21 | $1.15M | 67,122 |
| Mar 6, 2026↗ | KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | Sell | 2,628 | $204.86 | $538.4K | 13,441 |
| Mar 6, 2026↗ | Plewman Patrick | officer: SVP for Diagnostic Services | Sell | 2,855 | $206.21 | $588.7K | 15,198 |
| Mar 6, 2026↗ | PREVOZNIK MICHAEL E | officer: SVP & General Counsel | Sell | 3,878 | $206.21 | $799.7K | 37,557 |
| Mar 4, 2026↗ | Davis J. E. | director, officer: CEO and President | Sell | 20,000 | $212.52 | $4.25M | 117,185 |
| Mar 4, 2026↗ | Doherty Catherine T. | officer: EVP, Regional Businesses | Sell | 1,264 | $207.73 | $262.6K | 67,122 |
| Mar 4, 2026↗ | Plewman Patrick | officer: SVP for Diagnostic Services | Sell | 820 | $207.73 | $170.3K | 15,198 |
| Mar 4, 2026↗ | PREVOZNIK MICHAEL E | officer: SVP & General Counsel | Sell | 1,052 | $207.73 | $218.5K | 37,557 |
| Feb 20, 2026↗ | Doherty Catherine T. | officer: EVP, Regional Businesses | Sell | 1,433 | $204.83 | $293.5K | 68,402 |
| Feb 20, 2026↗ | Plewman Patrick | officer: SVP for Diagnostic Services | Sell | 958 | $204.83 | $196.2K | 15,838 |
| Feb 20, 2026↗ | PREVOZNIK MICHAEL E | officer: SVP & General Counsel | Sell | 1,111 | $204.83 | $227.6K | 38,371 |
| Feb 18, 2026↗ | Davis J. E. | CEO and President | Sell | 6,184 | $208.16 | $1.29M | 0 |
| Feb 18, 2026↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 450 | $207.58 | $93.4K | 0 |
| Feb 18, 2026↗ | Deppe Michael J | SVP, Corp. Controller & CAO | Sell | 182 | $208.37 | $37.9K | 0 |
| Feb 18, 2026↗ | Doherty Catherine T. | EVP, Regional Businesses | Sell | 2,594 | $206.30 | $535.1K | 0 |
| Feb 18, 2026↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 527 | $207.72 | $109.5K | 0 |
| Feb 18, 2026↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 1,495 | $206.10 | $308.1K | 0 |
| Feb 18, 2026↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 1,759 | $206.14 | $362.6K | 0 |
| Feb 18, 2026↗ | SAMAD SAM | Executive Vice President & CFO | Sell | 1,865 | $208.37 | $388.6K | 0 |
| Feb 17, 2026↗ | Doherty Catherine T. | officer: EVP, Regional Businesses | Sell | 26,165 | $206.15 | $5.39M | 83,660 |
| Feb 13, 2026↗ | Doherty Catherine T. | EVP, Regional Businesses | Sell | 26,165 | $206.15 | $5.39M | 0 |
| Feb 12, 2026↗ | Plewman Patrick | officer: SVP for Diagnostic Services | Sell | 5,662 | $204.00 | $1.16M | 15,381 |
| Jan 28, 2026↗ | CARTER ROBERT B | Director | Sell | 6 | $183.51 | $1.1K | 0 |
| Jan 28, 2026↗ | Gregg Vicky B | Director | Sell | 67 | $183.51 | $12.3K | 0 |
| Jan 28, 2026↗ | Lassiter Wright III | Director | Sell | 7 | $183.51 | $1.3K | 0 |
| Jan 28, 2026↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 5,662 | $204.00 | $1.16M | 0 |
| Nov 28, 2025↗ | Davis J. E. | CEO and President | Sell | 55,093 | $192.22 | $10.59M | 0 |
| Nov 28, 2025↗ | Gregg Vicky B | Director | Sell | 1,250 | $191.76 | $239.7K | 0 |
| Nov 20, 2025↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 7,946 | $187.35 | $1.49M | 0 |
| Nov 7, 2025↗ | Davis J. E. | CEO and President | Sell | 7,143 | $175.57 | $1.25M | 0 |
| Oct 24, 2025↗ | PFEIFFER GARY M | Director | Sell | 1,482 | $182.40 | $270.3K | 0 |
| Sep 30, 2025↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 227 | $188.13 | $42.7K | 0 |
| Sep 25, 2025↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 28,463 | $187.12 | $5.33M | 0 |
| Aug 25, 2025↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 1,975 | $185.00 | $365.4K | 0 |
| Aug 21, 2025↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 4,532 | $183.00 | $829.4K | 0 |
| Aug 19, 2025↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 1,975 | $180.00 | $355.5K | 0 |
| Aug 15, 2025↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 123 | $175.91 | $21.6K | 0 |
| Aug 8, 2025↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 5,535 | $175.00 | $968.6K | 0 |
| Aug 1, 2025↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 10,479 | $167.95 | $1.76M | 0 |
| Jul 25, 2025↗ | CARTER ROBERT B | Director | Sell | 7 | $167.50 | $1.2K | 0 |
| Jul 25, 2025↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 17 | $167.49 | $2.8K | 0 |
| Jul 25, 2025↗ | Gregg Vicky B | Director | Sell | 79 | $167.49 | $13.2K | 0 |
| Jul 25, 2025↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 27 | $167.50 | $4.5K | 0 |
| Jul 25, 2025↗ | Lassiter Wright III | Director | Sell | 7 | $167.50 | $1.2K | 0 |
| Jul 25, 2025↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 80 | $167.49 | $13.4K | 0 |
| Jul 25, 2025↗ | SAMAD SAM | Executive Vice President & CFO | Sell | 72 | $167.50 | $12.1K | 0 |
| Jul 17, 2025↗ | SAMAD SAM | Executive Vice President & CFO | Sell | 850 | $169.01 | $143.7K | 0 |
| May 14, 2025↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 1,748 | $175.51 | $306.8K | 0 |
| May 2, 2025↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 25 | $164.42 | $4.1K | 0 |
| May 2, 2025↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 27 | $164.42 | $4.4K | 0 |
| May 2, 2025↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 81 | $164.42 | $13.3K | 0 |
| May 2, 2025↗ | SAMAD SAM | Executive Vice President & CFO | Sell | 74 | $164.42 | $12.2K | 0 |
| Apr 4, 2025↗ | Davis J. E. | CEO and President | Sell | 39,191 | $168.46 | $6.60M | 0 |
| Apr 4, 2025↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 2,555 | $170.00 | $434.4K | 0 |
| Mar 28, 2025↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 256 | $166.71 | $42.7K | 0 |
| Mar 28, 2025↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 162 | $166.71 | $27.0K | 0 |
| Mar 19, 2025↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 4,643 | $170.00 | $789.3K | 0 |
| Mar 7, 2025↗ | Doherty Catherine T. | EVP, Regional Businesses | Sell | 5,370 | $174.13 | $935.1K | 0 |
| Mar 5, 2025↗ | Davis J. E. | CEO and President | Sell | 33,318 | $173.74 | $5.79M | 0 |
| Mar 5, 2025↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 1,823 | $173.74 | $316.7K | 0 |
| Mar 5, 2025↗ | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 2,559 | $173.74 | $444.6K | 0 |
| Mar 5, 2025↗ | Doherty Catherine T. | EVP, Regional Businesses | Sell | 6,120 | $173.98 | $1.06M | 0 |
| Mar 5, 2025↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 2,871 | $173.74 | $498.8K | 0 |
| Mar 5, 2025↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 2,386 | $173.74 | $414.5K | 0 |
| Mar 5, 2025↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 4,820 | $173.99 | $838.6K | 0 |
| Mar 5, 2025↗ | SAMAD SAM | Executive Vice President & CFO | Sell | 7,684 | $173.74 | $1.34M | 0 |
| Feb 28, 2025↗ | Davis J. E. | CEO and President | Sell | 2,966 | $171.75 | $509.4K | 0 |
| Feb 28, 2025↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 214 | $171.75 | $36.8K | 0 |
| Feb 28, 2025↗ | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 88 | $171.75 | $15.1K | 0 |
| Feb 28, 2025↗ | Doherty Catherine T. | EVP, Regional Businesses | Sell | 1,279 | $172.30 | $220.4K | 0 |
| Feb 28, 2025↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 233 | $171.75 | $40.0K | 0 |
| Feb 28, 2025↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 229 | $171.75 | $39.3K | 0 |
| Feb 28, 2025↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 814 | $172.31 | $140.3K | 0 |
| Feb 28, 2025↗ | SAMAD SAM | Executive Vice President & CFO | Sell | 869 | $171.75 | $149.3K | 0 |
| Feb 21, 2025↗ | Davis J. E. | CEO and President | Sell | 2,936 | $169.71 | $498.3K | 0 |
| Feb 21, 2025↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 242 | $169.71 | $41.1K | 0 |
| Feb 21, 2025↗ | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 99 | $169.71 | $16.8K | 0 |
| Feb 21, 2025↗ | Doherty Catherine T. | EVP, Regional Businesses | Sell | 1,434 | $170.51 | $244.5K | 0 |
| Feb 21, 2025↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 287 | $169.71 | $48.7K | 0 |
| Feb 21, 2025↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 320 | $169.71 | $54.3K | 0 |
| Feb 21, 2025↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 978 | $170.50 | $166.8K | 0 |
| Feb 21, 2025↗ | SAMAD SAM | Executive Vice President & CFO | Sell | 1,031 | $169.71 | $175.0K | 0 |
| Feb 7, 2025↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 403 | $164.30 | $66.2K | 0 |
| Feb 7, 2025↗ | Gregg Vicky B | Director | Sell | 1,250 | $164.57 | $205.7K | 0 |
| Jan 29, 2025↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 4 | $158.03 | $632.10 | 0 |
| Jan 29, 2025↗ | Gregg Vicky B | Director | Sell | 72 | $158.04 | $11.4K | 0 |
| Jan 29, 2025↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 12 | $158.03 | $1.9K | 0 |
| Jan 29, 2025↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 57 | $158.04 | $9.0K | 0 |
| Jan 29, 2025↗ | SAMAD SAM | Executive Vice President & CFO | Sell | 35 | $158.04 | $5.5K | 0 |
| Nov 29, 2024↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 35,146 | $163.07 | $5.73M | 0 |
| Nov 27, 2024↗ | Doherty Catherine T. | EVP, Regional Businesses | Sell | 33,103 | $162.99 | $5.40M | 0 |
| Nov 6, 2024↗ | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 18,755 | $154.05 | $2.89M | 0 |
| Oct 28, 2024↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 1,775 | $156.92 | $278.5K | 0 |
| Oct 21, 2024↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 4 | $149.39 | $597.55 | 0 |
| Oct 21, 2024↗ | Gregg Vicky B | Director | Sell | 76 | $149.37 | $11.4K | 0 |
| Oct 21, 2024↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 21 | $149.37 | $3.1K | 0 |
| Oct 21, 2024↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 60 | $149.37 | $9.0K | 0 |
| Oct 21, 2024↗ | SAMAD SAM | Executive Vice President & CFO | Sell | 37 | $149.37 | $5.5K | 0 |
| Sep 24, 2024↗ | GARDNER MARK A | SVP of Molecular Gen & Oncol | Sell | 120 | $155.70 | $18.7K | 0 |
| Aug 29, 2024↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 32,551 | $154.97 | $5.04M | 0 |
| Aug 28, 2024↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 1,990 | $153.26 | $305.0K | 0 |
| Aug 14, 2024↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 74 | $149.46 | $11.1K | 0 |
| Jul 24, 2024↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 426 | $143.13 | $61.0K | 0 |
| Jul 22, 2024↗ | Gregg Vicky B | Director | Sell | 77 | $146.97 | $11.3K | 0 |
| Jul 22, 2024↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 31 | $146.97 | $4.6K | 0 |
| Jul 22, 2024↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 60 | $146.97 | $8.8K | 0 |
| Jul 22, 2024↗ | SAMAD SAM | Executive Vice President & CFO | Sell | 21 | $146.97 | $3.1K | 0 |
| Jul 16, 2024↗ | SAMAD SAM | Executive Vice President & CFO | Sell | 3,910 | $142.65 | $557.8K | 0 |
| Apr 29, 2024↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 1,760 | $140.00 | $246.4K | 0 |
| Mar 26, 2024↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 170 | $128.11 | $21.8K | 0 |
| Mar 26, 2024↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 114 | $128.11 | $14.6K | 0 |
| Feb 28, 2024↗ | Davis J. E. | CEO and President | Sell | 5,020 | $126.36 | $634.3K | 0 |
| Feb 28, 2024↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 225 | $126.36 | $28.4K | 0 |
| Feb 28, 2024↗ | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 109 | $126.36 | $13.8K | 0 |
| Feb 28, 2024↗ | Doherty Catherine T. | EVP, Regional Businesses | Sell | 7,945 | $126.44 | $1.00M | 0 |
| Feb 28, 2024↗ | GARDNER MARK A | SVP of Molecular Gen & Oncol | Sell | 262 | $126.36 | $33.1K | 0 |
| Feb 28, 2024↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 273 | $126.36 | $34.5K | 0 |
| Feb 28, 2024↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 333 | $126.36 | $42.1K | 0 |
| Feb 28, 2024↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 6,472 | $125.94 | $815.1K | 0 |
| Feb 28, 2024↗ | SAMAD SAM | Executive Vice President & CFO | Sell | 656 | $126.36 | $82.9K | 0 |
| Feb 23, 2024↗ | Davis J. E. | CEO and President | Sell | 6,525 | $125.02 | $815.8K | 0 |
| Feb 23, 2024↗ | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 631 | $125.02 | $78.9K | 0 |
| Feb 23, 2024↗ | Doherty Catherine T. | EVP, Regional Businesses | Sell | 3,757 | $125.02 | $469.7K | 0 |
| Feb 23, 2024↗ | Gregg Vicky B | Director | Sell | 2,500 | $126.64 | $316.6K | 0 |
| Feb 23, 2024↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 619 | $125.02 | $77.4K | 0 |
| Feb 23, 2024↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 869 | $125.02 | $108.6K | 0 |
| Feb 23, 2024↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 2,825 | $125.02 | $353.2K | 0 |
| Feb 21, 2024↗ | Davis J. E. | CEO and President | Sell | 762 | $125.02 | $95.3K | 0 |
| Feb 21, 2024↗ | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 89 | $125.02 | $11.1K | 0 |
| Feb 21, 2024↗ | Doherty Catherine T. | EVP, Regional Businesses | Sell | 1,314 | $125.72 | $165.2K | 0 |
| Feb 21, 2024↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 102 | $125.02 | $12.8K | 0 |
| Feb 21, 2024↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 139 | $125.02 | $17.4K | 0 |
| Feb 21, 2024↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 1,068 | $125.71 | $134.3K | 0 |
| Sep 25, 2023↗ | GARDNER MARK A | SVP of Molecular Gen & Oncol | Sell | 116 | $126.22 | $14.6K | 0 |
| Aug 15, 2023↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 74 | $135.23 | $10.0K | 0 |
| Jul 14, 2023↗ | SAMAD SAM | Executive Vice President & CFO | Sell | 3,909 | $140.18 | $548.0K | 0 |
| Apr 24, 2023↗ | Gregg Vicky B | Director | Sell | 72 | $143.08 | $10.3K | 0 |
| Apr 24, 2023↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 25 | $143.08 | $3.6K | 0 |
| Apr 24, 2023↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 44 | $143.08 | $6.3K | 0 |
| Mar 24, 2023↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 170 | $134.25 | $22.8K | 0 |
| Mar 24, 2023↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 99 | $134.25 | $13.3K | 0 |
| Mar 6, 2023↗ | Davis J. E. | CEO and President | Sell | 8,036 | $147.86 | $1.19M | 0 |
| Mar 6, 2023↗ | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 682 | $147.86 | $100.8K | 0 |
| Mar 6, 2023↗ | Doherty Catherine T. | SVP, Regional Businesses | Sell | 9,917 | $143.95 | $1.43M | 0 |
| Mar 6, 2023↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 583 | $147.86 | $86.2K | 0 |
| Mar 6, 2023↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 799 | $147.86 | $118.1K | 0 |
| Mar 6, 2023↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 8,595 | $143.82 | $1.24M | 0 |
| Mar 6, 2023↗ | RUSCKOWSKI STEPHEN H | Director | Sell | 38,604 | $147.86 | $5.71M | 0 |
| Mar 3, 2023↗ | Doherty Catherine T. | SVP, Regional Businesses | Sell | 717 | $140.63 | $100.8K | 0 |
| Mar 1, 2023↗ | Davis J. E. | CEO and President | Sell | 1,292 | $140.69 | $181.8K | 0 |
| Mar 1, 2023↗ | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 68 | $140.69 | $9.6K | 0 |
| Mar 1, 2023↗ | Doherty Catherine T. | SVP, Regional Businesses | Sell | 392 | $140.69 | $55.2K | 0 |
| Mar 1, 2023↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 65 | $140.69 | $9.1K | 0 |
| Mar 1, 2023↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 90 | $140.69 | $12.7K | 0 |
| Mar 1, 2023↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 913 | $139.29 | $127.2K | 0 |
| Mar 1, 2023↗ | RUSCKOWSKI STEPHEN H | Director | Sell | 3,496 | $140.69 | $491.9K | 0 |
| Feb 23, 2023↗ | Davis J. E. | CEO and President | Sell | 1,473 | $147.86 | $217.8K | 0 |
| Feb 23, 2023↗ | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 188 | $147.86 | $27.8K | 0 |
| Feb 23, 2023↗ | Doherty Catherine T. | SVP, Regional Businesses | Sell | 2,652 | $143.76 | $381.2K | 0 |
| Feb 23, 2023↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 195 | $147.86 | $28.8K | 0 |
| Feb 23, 2023↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 245 | $147.86 | $36.2K | 0 |
| Feb 23, 2023↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 2,226 | $143.77 | $320.0K | 0 |
| Feb 23, 2023↗ | RUSCKOWSKI STEPHEN H | Director | Sell | 5,826 | $147.86 | $861.4K | 0 |
| Feb 1, 2023↗ | Gregg Vicky B | Director | Sell | 64 | $146.75 | $9.4K | 0 |
| Feb 1, 2023↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 13 | $146.75 | $1.9K | 0 |
| Feb 1, 2023↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 27 | $146.75 | $4.0K | 0 |
| Dec 1, 2022↗ | RING TIMOTHY M | Director | Sell | 2,025 | $152.50 | $308.8K | 0 |
| Nov 28, 2022↗ | Doherty Catherine T. | SVP, Regional Businesses | Sell | 40,765 | $149.18 | $6.08M | 0 |
| Nov 1, 2022↗ | RING TIMOTHY M | Director | Sell | 2,000 | $144.06 | $288.1K | 0 |
| Oct 26, 2022↗ | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Sell | 15,497 | $145.00 | $2.25M | 0 |
| Oct 19, 2022↗ | Gregg Vicky B | Director | Sell | 74 | $127.67 | $9.4K | 0 |
| Oct 3, 2022↗ | RING TIMOTHY M | Director | Sell | 2,000 | $123.39 | $246.8K | 0 |
| Sep 1, 2022↗ | RING TIMOTHY M | Director | Sell | 2,000 | $125.02 | $250.0K | 0 |
| Aug 1, 2022↗ | RING TIMOTHY M | Director | Sell | 2,000 | $136.04 | $272.1K | 0 |
| Jul 20, 2022↗ | Gregg Vicky B | Director | Sell | 70 | $134.47 | $9.4K | 0 |
| Jul 1, 2022↗ | RING TIMOTHY M | Director | Sell | 2,000 | $133.47 | $266.9K | 0 |
| May 25, 2022↗ | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 24,891 | $140.89 | $3.51M | 0 |
| May 23, 2022↗ | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 359,874 | $140.13 | $50.43M | 0 |
| May 18, 2022↗ | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Sell | 8 | $136.98 | $1.1K | 0 |
| May 17, 2022↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 50,604 | $139.97 | $7.08M | 0 |
| Apr 18, 2022↗ | Gregg Vicky B | Director | Sell | 61 | $134.88 | $8.2K | 0 |
| Mar 7, 2022↗ | Davis J. E. | EVP-Gen. Diagnostics/CEO Elect | Sell | 10,330 | $130.09 | $1.34M | 0 |
| Mar 7, 2022↗ | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Sell | 914 | $130.09 | $118.9K | 0 |
| Mar 7, 2022↗ | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sell | 13,392 | $132.78 | $1.78M | 0 |
| Mar 7, 2022↗ | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Sell | 7,947 | $130.09 | $1.03M | 0 |
| Mar 7, 2022↗ | GUINAN MARK | Executive Vice President & CFO | Sell | 10,475 | $130.09 | $1.36M | 0 |
| Mar 7, 2022↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 11,544 | $132.85 | $1.53M | 0 |
| Mar 7, 2022↗ | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 32,570 | $130.09 | $4.24M | 0 |
| Feb 28, 2022↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 661 | $130.00 | $85.9K | 0 |
| Feb 24, 2022↗ | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sell | 2,750 | $126.26 | $347.2K | 0 |
| Feb 24, 2022↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 1,669 | $126.26 | $210.7K | 0 |
| Feb 23, 2022↗ | Davis J. E. | EVP-Gen. Diagnostics/CEO Elect | Sell | 2,436 | $130.13 | $317.0K | 0 |
| Feb 23, 2022↗ | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Sell | 313 | $130.13 | $40.7K | 0 |
| Feb 23, 2022↗ | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sell | 1,574 | $130.13 | $204.8K | 0 |
| Feb 23, 2022↗ | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Sell | 1,977 | $130.13 | $257.3K | 0 |
| Feb 23, 2022↗ | GUINAN MARK | Executive Vice President & CFO | Sell | 2,367 | $130.13 | $308.0K | 0 |
| Feb 23, 2022↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 1,339 | $130.13 | $174.2K | 0 |
| Feb 23, 2022↗ | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 9,718 | $130.12 | $1.26M | 0 |
| Nov 29, 2021↗ | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sell | 37,565 | $156.81 | $5.89M | 0 |
| Jul 28, 2021↗ | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 149,244 | $140.19 | $20.92M | 0 |
| Jul 27, 2021↗ | WILENSKY GAIL R | Director | Sell | 12,222 | $139.30 | $1.70M | 0 |
| Jul 26, 2021↗ | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 38,601 | $140.01 | $5.40M | 0 |
| May 18, 2021↗ | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Sell | 5 | $136.60 | $683.00 | 0 |
| May 7, 2021↗ | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sell | 8,536 | $139.96 | $1.19M | 0 |
| May 5, 2021↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 44,939 | $137.00 | $6.16M | 0 |
| Mar 9, 2021↗ | Davis J. E. | EVP, General Diagnostics | Sell | 8,334 | $115.42 | $961.9K | 0 |
| Mar 9, 2021↗ | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Sell | 684 | $115.42 | $78.9K | 0 |
| Mar 9, 2021↗ | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sell | 5,066 | $115.42 | $584.7K | 0 |
| Mar 9, 2021↗ | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Sell | 6,165 | $115.42 | $711.6K | 0 |
| Mar 9, 2021↗ | GUINAN MARK | Executive Vice President & CFO | Sell | 6,403 | $115.42 | $739.0K | 0 |
| Mar 9, 2021↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 9,791 | $118.30 | $1.16M | 0 |
| Mar 9, 2021↗ | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 25,887 | $115.42 | $2.99M | 0 |
| Feb 25, 2021↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 801 | $115.49 | $92.5K | 0 |
| Feb 23, 2021↗ | Davis J. E. | EVP, General Diagnostics | Sell | 2,056 | $121.17 | $249.1K | 0 |
| Feb 23, 2021↗ | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Sell | 262 | $121.17 | $31.7K | 0 |
| Feb 23, 2021↗ | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sell | 1,320 | $121.17 | $159.9K | 0 |
| Feb 23, 2021↗ | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Sell | 1,628 | $121.17 | $197.3K | 0 |
| Feb 23, 2021↗ | GUINAN MARK | Executive Vice President & CFO | Sell | 1,371 | $121.17 | $166.1K | 0 |
| Feb 23, 2021↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 2,336 | $119.02 | $278.0K | 0 |
| Feb 23, 2021↗ | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 7,352 | $121.17 | $890.8K | 0 |
DGX Insider Buying Activity
The following table shows recent insider purchases of Quest Diagnostics Incorporated (DGX) stock reported via SEC Form 4 filings.
No insider buying activity found for DGX in the last 12 months.
DGX Insider Selling Activity
The following table shows recent insider sales of Quest Diagnostics Incorporated (DGX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 6, 2026↗ | Doherty Catherine T. | officer: EVP, Regional Businesses | Sell | 5,558 | $206.21 | $1.15M | 67,122 |
| Mar 6, 2026↗ | KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | Sell | 2,628 | $204.86 | $538.4K | 13,441 |
| Mar 6, 2026↗ | Plewman Patrick | officer: SVP for Diagnostic Services | Sell | 2,855 | $206.21 | $588.7K | 15,198 |
| Mar 6, 2026↗ | PREVOZNIK MICHAEL E | officer: SVP & General Counsel | Sell | 3,878 | $206.21 | $799.7K | 37,557 |
| Mar 4, 2026↗ | Davis J. E. | director, officer: CEO and President | Sell | 20,000 | $212.52 | $4.25M | 117,185 |
| Mar 4, 2026↗ | Doherty Catherine T. | officer: EVP, Regional Businesses | Sell | 1,264 | $207.73 | $262.6K | 67,122 |
| Mar 4, 2026↗ | Plewman Patrick | officer: SVP for Diagnostic Services | Sell | 820 | $207.73 | $170.3K | 15,198 |
| Mar 4, 2026↗ | PREVOZNIK MICHAEL E | officer: SVP & General Counsel | Sell | 1,052 | $207.73 | $218.5K | 37,557 |
| Feb 20, 2026↗ | Doherty Catherine T. | officer: EVP, Regional Businesses | Sell | 1,433 | $204.83 | $293.5K | 68,402 |
| Feb 20, 2026↗ | Plewman Patrick | officer: SVP for Diagnostic Services | Sell | 958 | $204.83 | $196.2K | 15,838 |
| Feb 20, 2026↗ | PREVOZNIK MICHAEL E | officer: SVP & General Counsel | Sell | 1,111 | $204.83 | $227.6K | 38,371 |
| Feb 18, 2026↗ | Davis J. E. | CEO and President | Sell | 6,184 | $208.16 | $1.29M | 0 |
| Feb 18, 2026↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 450 | $207.58 | $93.4K | 0 |
| Feb 18, 2026↗ | Deppe Michael J | SVP, Corp. Controller & CAO | Sell | 182 | $208.37 | $37.9K | 0 |
| Feb 18, 2026↗ | Doherty Catherine T. | EVP, Regional Businesses | Sell | 2,594 | $206.30 | $535.1K | 0 |
| Feb 18, 2026↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 527 | $207.72 | $109.5K | 0 |
| Feb 18, 2026↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 1,495 | $206.10 | $308.1K | 0 |
| Feb 18, 2026↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 1,759 | $206.14 | $362.6K | 0 |
| Feb 18, 2026↗ | SAMAD SAM | Executive Vice President & CFO | Sell | 1,865 | $208.37 | $388.6K | 0 |
| Feb 17, 2026↗ | Doherty Catherine T. | officer: EVP, Regional Businesses | Sell | 26,165 | $206.15 | $5.39M | 83,660 |
| Feb 13, 2026↗ | Doherty Catherine T. | EVP, Regional Businesses | Sell | 26,165 | $206.15 | $5.39M | 0 |
| Feb 12, 2026↗ | Plewman Patrick | officer: SVP for Diagnostic Services | Sell | 5,662 | $204.00 | $1.16M | 15,381 |
| Jan 28, 2026↗ | CARTER ROBERT B | Director | Sell | 6 | $183.51 | $1.1K | 0 |
| Jan 28, 2026↗ | Gregg Vicky B | Director | Sell | 67 | $183.51 | $12.3K | 0 |
| Jan 28, 2026↗ | Lassiter Wright III | Director | Sell | 7 | $183.51 | $1.3K | 0 |
| Jan 28, 2026↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 5,662 | $204.00 | $1.16M | 0 |
| Nov 28, 2025↗ | Davis J. E. | CEO and President | Sell | 55,093 | $192.22 | $10.59M | 0 |
| Nov 28, 2025↗ | Gregg Vicky B | Director | Sell | 1,250 | $191.76 | $239.7K | 0 |
| Nov 20, 2025↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 7,946 | $187.35 | $1.49M | 0 |
| Nov 7, 2025↗ | Davis J. E. | CEO and President | Sell | 7,143 | $175.57 | $1.25M | 0 |
| Oct 24, 2025↗ | PFEIFFER GARY M | Director | Sell | 1,482 | $182.40 | $270.3K | 0 |
| Sep 30, 2025↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 227 | $188.13 | $42.7K | 0 |
| Sep 25, 2025↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 28,463 | $187.12 | $5.33M | 0 |
| Aug 25, 2025↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 1,975 | $185.00 | $365.4K | 0 |
| Aug 21, 2025↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 4,532 | $183.00 | $829.4K | 0 |
| Aug 19, 2025↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 1,975 | $180.00 | $355.5K | 0 |
| Aug 15, 2025↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 123 | $175.91 | $21.6K | 0 |
| Aug 8, 2025↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 5,535 | $175.00 | $968.6K | 0 |
| Aug 1, 2025↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 10,479 | $167.95 | $1.76M | 0 |
| Jul 25, 2025↗ | CARTER ROBERT B | Director | Sell | 7 | $167.50 | $1.2K | 0 |
| Jul 25, 2025↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 17 | $167.49 | $2.8K | 0 |
| Jul 25, 2025↗ | Gregg Vicky B | Director | Sell | 79 | $167.49 | $13.2K | 0 |
| Jul 25, 2025↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 27 | $167.50 | $4.5K | 0 |
| Jul 25, 2025↗ | Lassiter Wright III | Director | Sell | 7 | $167.50 | $1.2K | 0 |
| Jul 25, 2025↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 80 | $167.49 | $13.4K | 0 |
| Jul 25, 2025↗ | SAMAD SAM | Executive Vice President & CFO | Sell | 72 | $167.50 | $12.1K | 0 |
| Jul 17, 2025↗ | SAMAD SAM | Executive Vice President & CFO | Sell | 850 | $169.01 | $143.7K | 0 |
| May 14, 2025↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 1,748 | $175.51 | $306.8K | 0 |
| May 2, 2025↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 25 | $164.42 | $4.1K | 0 |
| May 2, 2025↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 27 | $164.42 | $4.4K | 0 |
| May 2, 2025↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 81 | $164.42 | $13.3K | 0 |
| May 2, 2025↗ | SAMAD SAM | Executive Vice President & CFO | Sell | 74 | $164.42 | $12.2K | 0 |
| Apr 4, 2025↗ | Davis J. E. | CEO and President | Sell | 39,191 | $168.46 | $6.60M | 0 |
| Apr 4, 2025↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 2,555 | $170.00 | $434.4K | 0 |
| Mar 28, 2025↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 256 | $166.71 | $42.7K | 0 |
| Mar 28, 2025↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 162 | $166.71 | $27.0K | 0 |
| Mar 19, 2025↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 4,643 | $170.00 | $789.3K | 0 |
| Mar 7, 2025↗ | Doherty Catherine T. | EVP, Regional Businesses | Sell | 5,370 | $174.13 | $935.1K | 0 |
| Mar 5, 2025↗ | Davis J. E. | CEO and President | Sell | 33,318 | $173.74 | $5.79M | 0 |
| Mar 5, 2025↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 1,823 | $173.74 | $316.7K | 0 |
| Mar 5, 2025↗ | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 2,559 | $173.74 | $444.6K | 0 |
| Mar 5, 2025↗ | Doherty Catherine T. | EVP, Regional Businesses | Sell | 6,120 | $173.98 | $1.06M | 0 |
| Mar 5, 2025↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 2,871 | $173.74 | $498.8K | 0 |
| Mar 5, 2025↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 2,386 | $173.74 | $414.5K | 0 |
| Mar 5, 2025↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 4,820 | $173.99 | $838.6K | 0 |
| Mar 5, 2025↗ | SAMAD SAM | Executive Vice President & CFO | Sell | 7,684 | $173.74 | $1.34M | 0 |
| Feb 28, 2025↗ | Davis J. E. | CEO and President | Sell | 2,966 | $171.75 | $509.4K | 0 |
| Feb 28, 2025↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 214 | $171.75 | $36.8K | 0 |
| Feb 28, 2025↗ | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 88 | $171.75 | $15.1K | 0 |
| Feb 28, 2025↗ | Doherty Catherine T. | EVP, Regional Businesses | Sell | 1,279 | $172.30 | $220.4K | 0 |
| Feb 28, 2025↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 233 | $171.75 | $40.0K | 0 |
| Feb 28, 2025↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 229 | $171.75 | $39.3K | 0 |
| Feb 28, 2025↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 814 | $172.31 | $140.3K | 0 |
| Feb 28, 2025↗ | SAMAD SAM | Executive Vice President & CFO | Sell | 869 | $171.75 | $149.3K | 0 |
| Feb 21, 2025↗ | Davis J. E. | CEO and President | Sell | 2,936 | $169.71 | $498.3K | 0 |
| Feb 21, 2025↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 242 | $169.71 | $41.1K | 0 |
| Feb 21, 2025↗ | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 99 | $169.71 | $16.8K | 0 |
| Feb 21, 2025↗ | Doherty Catherine T. | EVP, Regional Businesses | Sell | 1,434 | $170.51 | $244.5K | 0 |
| Feb 21, 2025↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 287 | $169.71 | $48.7K | 0 |
| Feb 21, 2025↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 320 | $169.71 | $54.3K | 0 |
| Feb 21, 2025↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 978 | $170.50 | $166.8K | 0 |
| Feb 21, 2025↗ | SAMAD SAM | Executive Vice President & CFO | Sell | 1,031 | $169.71 | $175.0K | 0 |
| Feb 7, 2025↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 403 | $164.30 | $66.2K | 0 |
| Feb 7, 2025↗ | Gregg Vicky B | Director | Sell | 1,250 | $164.57 | $205.7K | 0 |
| Jan 29, 2025↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 4 | $158.03 | $632.10 | 0 |
| Jan 29, 2025↗ | Gregg Vicky B | Director | Sell | 72 | $158.04 | $11.4K | 0 |
| Jan 29, 2025↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 12 | $158.03 | $1.9K | 0 |
| Jan 29, 2025↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 57 | $158.04 | $9.0K | 0 |
| Jan 29, 2025↗ | SAMAD SAM | Executive Vice President & CFO | Sell | 35 | $158.04 | $5.5K | 0 |
| Nov 29, 2024↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 35,146 | $163.07 | $5.73M | 0 |
| Nov 27, 2024↗ | Doherty Catherine T. | EVP, Regional Businesses | Sell | 33,103 | $162.99 | $5.40M | 0 |
| Nov 6, 2024↗ | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 18,755 | $154.05 | $2.89M | 0 |
| Oct 28, 2024↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 1,775 | $156.92 | $278.5K | 0 |
| Oct 21, 2024↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 4 | $149.39 | $597.55 | 0 |
| Oct 21, 2024↗ | Gregg Vicky B | Director | Sell | 76 | $149.37 | $11.4K | 0 |
| Oct 21, 2024↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 21 | $149.37 | $3.1K | 0 |
| Oct 21, 2024↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 60 | $149.37 | $9.0K | 0 |
| Oct 21, 2024↗ | SAMAD SAM | Executive Vice President & CFO | Sell | 37 | $149.37 | $5.5K | 0 |
| Sep 24, 2024↗ | GARDNER MARK A | SVP of Molecular Gen & Oncol | Sell | 120 | $155.70 | $18.7K | 0 |
| Aug 29, 2024↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 32,551 | $154.97 | $5.04M | 0 |
| Aug 28, 2024↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 1,990 | $153.26 | $305.0K | 0 |
| Aug 14, 2024↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 74 | $149.46 | $11.1K | 0 |
| Jul 24, 2024↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 426 | $143.13 | $61.0K | 0 |
| Jul 22, 2024↗ | Gregg Vicky B | Director | Sell | 77 | $146.97 | $11.3K | 0 |
| Jul 22, 2024↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 31 | $146.97 | $4.6K | 0 |
| Jul 22, 2024↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 60 | $146.97 | $8.8K | 0 |
| Jul 22, 2024↗ | SAMAD SAM | Executive Vice President & CFO | Sell | 21 | $146.97 | $3.1K | 0 |
| Jul 16, 2024↗ | SAMAD SAM | Executive Vice President & CFO | Sell | 3,910 | $142.65 | $557.8K | 0 |
| Apr 29, 2024↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 1,760 | $140.00 | $246.4K | 0 |
| Mar 26, 2024↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 170 | $128.11 | $21.8K | 0 |
| Mar 26, 2024↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 114 | $128.11 | $14.6K | 0 |
| Feb 28, 2024↗ | Davis J. E. | CEO and President | Sell | 5,020 | $126.36 | $634.3K | 0 |
| Feb 28, 2024↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 225 | $126.36 | $28.4K | 0 |
| Feb 28, 2024↗ | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 109 | $126.36 | $13.8K | 0 |
| Feb 28, 2024↗ | Doherty Catherine T. | EVP, Regional Businesses | Sell | 7,945 | $126.44 | $1.00M | 0 |
| Feb 28, 2024↗ | GARDNER MARK A | SVP of Molecular Gen & Oncol | Sell | 262 | $126.36 | $33.1K | 0 |
| Feb 28, 2024↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 273 | $126.36 | $34.5K | 0 |
| Feb 28, 2024↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 333 | $126.36 | $42.1K | 0 |
| Feb 28, 2024↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 6,472 | $125.94 | $815.1K | 0 |
| Feb 28, 2024↗ | SAMAD SAM | Executive Vice President & CFO | Sell | 656 | $126.36 | $82.9K | 0 |
| Feb 23, 2024↗ | Davis J. E. | CEO and President | Sell | 6,525 | $125.02 | $815.8K | 0 |
| Feb 23, 2024↗ | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 631 | $125.02 | $78.9K | 0 |
| Feb 23, 2024↗ | Doherty Catherine T. | EVP, Regional Businesses | Sell | 3,757 | $125.02 | $469.7K | 0 |
| Feb 23, 2024↗ | Gregg Vicky B | Director | Sell | 2,500 | $126.64 | $316.6K | 0 |
| Feb 23, 2024↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 619 | $125.02 | $77.4K | 0 |
| Feb 23, 2024↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 869 | $125.02 | $108.6K | 0 |
| Feb 23, 2024↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 2,825 | $125.02 | $353.2K | 0 |
| Feb 21, 2024↗ | Davis J. E. | CEO and President | Sell | 762 | $125.02 | $95.3K | 0 |
| Feb 21, 2024↗ | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 89 | $125.02 | $11.1K | 0 |
| Feb 21, 2024↗ | Doherty Catherine T. | EVP, Regional Businesses | Sell | 1,314 | $125.72 | $165.2K | 0 |
| Feb 21, 2024↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 102 | $125.02 | $12.8K | 0 |
| Feb 21, 2024↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 139 | $125.02 | $17.4K | 0 |
| Feb 21, 2024↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 1,068 | $125.71 | $134.3K | 0 |
| Sep 25, 2023↗ | GARDNER MARK A | SVP of Molecular Gen & Oncol | Sell | 116 | $126.22 | $14.6K | 0 |
| Aug 15, 2023↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 74 | $135.23 | $10.0K | 0 |
| Jul 14, 2023↗ | SAMAD SAM | Executive Vice President & CFO | Sell | 3,909 | $140.18 | $548.0K | 0 |
| Apr 24, 2023↗ | Gregg Vicky B | Director | Sell | 72 | $143.08 | $10.3K | 0 |
| Apr 24, 2023↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 25 | $143.08 | $3.6K | 0 |
| Apr 24, 2023↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 44 | $143.08 | $6.3K | 0 |
| Mar 24, 2023↗ | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 170 | $134.25 | $22.8K | 0 |
| Mar 24, 2023↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 99 | $134.25 | $13.3K | 0 |
| Mar 6, 2023↗ | Davis J. E. | CEO and President | Sell | 8,036 | $147.86 | $1.19M | 0 |
| Mar 6, 2023↗ | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 682 | $147.86 | $100.8K | 0 |
| Mar 6, 2023↗ | Doherty Catherine T. | SVP, Regional Businesses | Sell | 9,917 | $143.95 | $1.43M | 0 |
| Mar 6, 2023↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 583 | $147.86 | $86.2K | 0 |
| Mar 6, 2023↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 799 | $147.86 | $118.1K | 0 |
| Mar 6, 2023↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 8,595 | $143.82 | $1.24M | 0 |
| Mar 6, 2023↗ | RUSCKOWSKI STEPHEN H | Director | Sell | 38,604 | $147.86 | $5.71M | 0 |
| Mar 3, 2023↗ | Doherty Catherine T. | SVP, Regional Businesses | Sell | 717 | $140.63 | $100.8K | 0 |
| Mar 1, 2023↗ | Davis J. E. | CEO and President | Sell | 1,292 | $140.69 | $181.8K | 0 |
| Mar 1, 2023↗ | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 68 | $140.69 | $9.6K | 0 |
| Mar 1, 2023↗ | Doherty Catherine T. | SVP, Regional Businesses | Sell | 392 | $140.69 | $55.2K | 0 |
| Mar 1, 2023↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 65 | $140.69 | $9.1K | 0 |
| Mar 1, 2023↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 90 | $140.69 | $12.7K | 0 |
| Mar 1, 2023↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 913 | $139.29 | $127.2K | 0 |
| Mar 1, 2023↗ | RUSCKOWSKI STEPHEN H | Director | Sell | 3,496 | $140.69 | $491.9K | 0 |
| Feb 23, 2023↗ | Davis J. E. | CEO and President | Sell | 1,473 | $147.86 | $217.8K | 0 |
| Feb 23, 2023↗ | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 188 | $147.86 | $27.8K | 0 |
| Feb 23, 2023↗ | Doherty Catherine T. | SVP, Regional Businesses | Sell | 2,652 | $143.76 | $381.2K | 0 |
| Feb 23, 2023↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 195 | $147.86 | $28.8K | 0 |
| Feb 23, 2023↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 245 | $147.86 | $36.2K | 0 |
| Feb 23, 2023↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 2,226 | $143.77 | $320.0K | 0 |
| Feb 23, 2023↗ | RUSCKOWSKI STEPHEN H | Director | Sell | 5,826 | $147.86 | $861.4K | 0 |
| Feb 1, 2023↗ | Gregg Vicky B | Director | Sell | 64 | $146.75 | $9.4K | 0 |
| Feb 1, 2023↗ | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 13 | $146.75 | $1.9K | 0 |
| Feb 1, 2023↗ | Plewman Patrick | SVP for Diagnostic Services | Sell | 27 | $146.75 | $4.0K | 0 |
| Dec 1, 2022↗ | RING TIMOTHY M | Director | Sell | 2,025 | $152.50 | $308.8K | 0 |
| Nov 28, 2022↗ | Doherty Catherine T. | SVP, Regional Businesses | Sell | 40,765 | $149.18 | $6.08M | 0 |
| Nov 1, 2022↗ | RING TIMOTHY M | Director | Sell | 2,000 | $144.06 | $288.1K | 0 |
| Oct 26, 2022↗ | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Sell | 15,497 | $145.00 | $2.25M | 0 |
| Oct 19, 2022↗ | Gregg Vicky B | Director | Sell | 74 | $127.67 | $9.4K | 0 |
| Oct 3, 2022↗ | RING TIMOTHY M | Director | Sell | 2,000 | $123.39 | $246.8K | 0 |
| Sep 1, 2022↗ | RING TIMOTHY M | Director | Sell | 2,000 | $125.02 | $250.0K | 0 |
| Aug 1, 2022↗ | RING TIMOTHY M | Director | Sell | 2,000 | $136.04 | $272.1K | 0 |
| Jul 20, 2022↗ | Gregg Vicky B | Director | Sell | 70 | $134.47 | $9.4K | 0 |
| Jul 1, 2022↗ | RING TIMOTHY M | Director | Sell | 2,000 | $133.47 | $266.9K | 0 |
| May 25, 2022↗ | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 24,891 | $140.89 | $3.51M | 0 |
| May 23, 2022↗ | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 359,874 | $140.13 | $50.43M | 0 |
| May 18, 2022↗ | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Sell | 8 | $136.98 | $1.1K | 0 |
| May 17, 2022↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 50,604 | $139.97 | $7.08M | 0 |
| Apr 18, 2022↗ | Gregg Vicky B | Director | Sell | 61 | $134.88 | $8.2K | 0 |
| Mar 7, 2022↗ | Davis J. E. | EVP-Gen. Diagnostics/CEO Elect | Sell | 10,330 | $130.09 | $1.34M | 0 |
| Mar 7, 2022↗ | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Sell | 914 | $130.09 | $118.9K | 0 |
| Mar 7, 2022↗ | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sell | 13,392 | $132.78 | $1.78M | 0 |
| Mar 7, 2022↗ | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Sell | 7,947 | $130.09 | $1.03M | 0 |
| Mar 7, 2022↗ | GUINAN MARK | Executive Vice President & CFO | Sell | 10,475 | $130.09 | $1.36M | 0 |
| Mar 7, 2022↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 11,544 | $132.85 | $1.53M | 0 |
| Mar 7, 2022↗ | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 32,570 | $130.09 | $4.24M | 0 |
| Feb 28, 2022↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 661 | $130.00 | $85.9K | 0 |
| Feb 24, 2022↗ | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sell | 2,750 | $126.26 | $347.2K | 0 |
| Feb 24, 2022↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 1,669 | $126.26 | $210.7K | 0 |
| Feb 23, 2022↗ | Davis J. E. | EVP-Gen. Diagnostics/CEO Elect | Sell | 2,436 | $130.13 | $317.0K | 0 |
| Feb 23, 2022↗ | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Sell | 313 | $130.13 | $40.7K | 0 |
| Feb 23, 2022↗ | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sell | 1,574 | $130.13 | $204.8K | 0 |
| Feb 23, 2022↗ | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Sell | 1,977 | $130.13 | $257.3K | 0 |
| Feb 23, 2022↗ | GUINAN MARK | Executive Vice President & CFO | Sell | 2,367 | $130.13 | $308.0K | 0 |
| Feb 23, 2022↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 1,339 | $130.13 | $174.2K | 0 |
| Feb 23, 2022↗ | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 9,718 | $130.12 | $1.26M | 0 |
| Nov 29, 2021↗ | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sell | 37,565 | $156.81 | $5.89M | 0 |
| Jul 28, 2021↗ | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 149,244 | $140.19 | $20.92M | 0 |
| Jul 27, 2021↗ | WILENSKY GAIL R | Director | Sell | 12,222 | $139.30 | $1.70M | 0 |
| Jul 26, 2021↗ | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 38,601 | $140.01 | $5.40M | 0 |
| May 18, 2021↗ | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Sell | 5 | $136.60 | $683.00 | 0 |
| May 7, 2021↗ | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sell | 8,536 | $139.96 | $1.19M | 0 |
| May 5, 2021↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 44,939 | $137.00 | $6.16M | 0 |
| Mar 9, 2021↗ | Davis J. E. | EVP, General Diagnostics | Sell | 8,334 | $115.42 | $961.9K | 0 |
| Mar 9, 2021↗ | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Sell | 684 | $115.42 | $78.9K | 0 |
| Mar 9, 2021↗ | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sell | 5,066 | $115.42 | $584.7K | 0 |
| Mar 9, 2021↗ | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Sell | 6,165 | $115.42 | $711.6K | 0 |
| Mar 9, 2021↗ | GUINAN MARK | Executive Vice President & CFO | Sell | 6,403 | $115.42 | $739.0K | 0 |
| Mar 9, 2021↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 9,791 | $118.30 | $1.16M | 0 |
| Mar 9, 2021↗ | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 25,887 | $115.42 | $2.99M | 0 |
| Feb 25, 2021↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 801 | $115.49 | $92.5K | 0 |
| Feb 23, 2021↗ | Davis J. E. | EVP, General Diagnostics | Sell | 2,056 | $121.17 | $249.1K | 0 |
| Feb 23, 2021↗ | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Sell | 262 | $121.17 | $31.7K | 0 |
| Feb 23, 2021↗ | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sell | 1,320 | $121.17 | $159.9K | 0 |
| Feb 23, 2021↗ | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Sell | 1,628 | $121.17 | $197.3K | 0 |
| Feb 23, 2021↗ | GUINAN MARK | Executive Vice President & CFO | Sell | 1,371 | $121.17 | $166.1K | 0 |
| Feb 23, 2021↗ | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 2,336 | $119.02 | $278.0K | 0 |
| Feb 23, 2021↗ | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 7,352 | $121.17 | $890.8K | 0 |
DGX Insiders
Similar Stocks to DGX
TMO
Thermo Fisher Scientific Inc.
$466.50-1.97%
$176.79B
DHR
Danaher Corporation
$186.78+0.28%
$131.71B
IDXX
IDEXX Laboratories, Inc.
$573.03+0.32%
$45.61B
IQV
IQVIA Holdings Inc.
$164.75+1.16%
$27.65B
NTRA
Natera, Inc.
$188.35-1.03%
$26.97B
MTD
Mettler-Toledo International Inc.
$1176.04+0.69%
$23.86B
EXAS
Exact Sciences Corporation
$103.58+0.30%
$19.77B
WAT
Waters Corporation
$285.96+0.93%
$19.48B